Meeder Asset Management Inc. acquired a new position in shares of Equifax, Inc. (NYSE:EFX - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 32,601 shares of the credit services provider's stock, valued at approximately $5,174,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. BlackRock Inc. acquired a new position in Equifax in the 2nd quarter valued at $1,491,357,000. State Street Corp lifted its holdings in shares of Equifax by 1.3% during the fourth quarter. State Street Corp now owns 5,056,441 shares of the credit services provider's stock worth $1,097,147,000 after buying an additional 66,289 shares in the last quarter. Soroban Capital Partners LP boosted its position in shares of Equifax by 310.5% in the first quarter. Soroban Capital Partners LP now owns 4,184,569 shares of the credit services provider's stock valued at $753,515,000 after acquiring an additional 3,165,120 shares during the period. Brown Advisory Inc. boosted its position in shares of Equifax by 57.2% in the fourth quarter. Brown Advisory Inc. now owns 2,809,879 shares of the credit services provider's stock valued at $609,693,000 after acquiring an additional 1,022,819 shares during the period. Finally, Bank of America Corp DE boosted its position in shares of Equifax by 36.5% in the first quarter. Bank of America Corp DE now owns 2,107,458 shares of the credit services provider's stock valued at $379,490,000 after acquiring an additional 563,880 shares during the period. Institutional investors and hedge funds own 96.20% of the company's stock.
Equifax Price Performance
Shares of NYSE:EFX opened at $176.80 on Tuesday. The firm has a 50 day moving average of $170.11 and a 200-day moving average of $178.32. Equifax, Inc. has a 12 month low of $150.74 and a 12 month high of $271.84. The company has a current ratio of 0.60, a quick ratio of 0.60 and a debt-to-equity ratio of 0.92. The stock has a market capitalization of $20.77 billion, a PE ratio of 31.07, a PEG ratio of 1.45 and a beta of 1.30.
Equifax (NYSE:EFX - Get Free Report) last posted its quarterly earnings results on Tuesday, July 21st. The credit services provider reported $2.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.20 by $0.05. The business had revenue of $1.70 billion for the quarter, compared to analyst estimates of $1.70 billion. Equifax had a net margin of 10.73% and a return on equity of 21.61%. The firm's revenue for the quarter was up 10.6% on a year-over-year basis. During the same quarter last year, the business posted $2.00 EPS. Equifax has set its Q3 2026 guidance at 2.150-2.250 EPS and its FY 2026 guidance at 8.390-8.690 EPS. On average, equities research analysts predict that Equifax, Inc. will post 8.57 EPS for the current fiscal year.
Insiders Place Their Bets
In other Equifax news, CEO Mark W. Begor sold 37,791 shares of the firm's stock in a transaction on Friday, July 24th. The stock was sold at an average price of $172.16, for a total value of $6,506,098.56. Following the sale, the chief executive officer owned 271,890 shares of the company's stock, valued at approximately $46,808,582.40. This trade represents a 12.20% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.70% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
A number of research firms recently commented on EFX. Jefferies Financial Group lowered their price target on shares of Equifax from $220.00 to $200.00 and set a "buy" rating on the stock in a research report on Friday, April 24th. Citigroup cut their price objective on shares of Equifax from $256.00 to $238.00 and set a "buy" rating for the company in a report on Wednesday, April 22nd. BMO Capital Markets decreased their target price on shares of Equifax from $195.00 to $179.00 and set a "market perform" rating on the stock in a research report on Monday, July 13th. Morgan Stanley lowered their target price on shares of Equifax from $243.00 to $225.00 and set an "overweight" rating on the stock in a report on Wednesday, July 22nd. Finally, Needham & Company LLC dropped their price target on shares of Equifax from $265.00 to $245.00 and set a "buy" rating for the company in a research report on Wednesday, July 22nd. Thirteen research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $215.79.
Check Out Our Latest Research Report on EFX
Equifax Profile
(
Free Report)
Equifax Inc NYSE: EFX is a global data, analytics and technology company that specializes in consumer and commercial credit reporting, decisioning tools and identity solutions. Headquartered in Atlanta, Georgia, Equifax is one of the three major consumer credit reporting agencies in the United States and provides credit information and related services to lenders, employers, governments and consumers worldwide.
The company's offerings include consumer credit reports and scores, credit monitoring and identity protection services, and a range of business-oriented products for risk management, fraud detection and compliance.
Further Reading
Want to see what other hedge funds are holding EFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Equifax, Inc. (NYSE:EFX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Equifax, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.
While Equifax currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.